Panuri Test for Suspected Pancreatic Cancer
Part of Cancer clinical trials.
This study tests a new diagnostic tool called Panuri to help detect pancreatic cancer in adults who have symptoms suggesting the disease. The test may help doctors identify pancreatic cancer earlier and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have symptoms that make your doctor suspect pancreatic cancer (such as jaundice, abdominal pain, weight loss, or digestive problems)
- Not have a prior pancreatic cancer diagnosis or pancreatic surgery
- Not have had cancer in the past 5 years or recent cancer treatment
- Not have certain kidney or liver diseases that could affect test results
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in tumor tissue that could help find pancreatic cancer earlier. You may be able to join if you are having surgery for a suspected pancreatic tumor and the final diagnosis is a precancerous condition or pancreatic cancer.
This study will see if people over 50 with new-onset diabetes can benefit from imaging scans (CT or endoscopic ultrasound) to help catch pancreatic ductal adenocarcinoma at an early stage. The goal is to screen those who might be at higher risk based on the END-PDAC score.
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
This is a “registry” study that collects health information from adults with pancreatic ductal adenocarcinoma before starting treatment. It may help researchers better understand the disease and how patients are managed in real life.
This trial is studying a new screening method (LINFU®) to find pancreatic cancer early in people who have no symptoms or known risk factors, to see if it can help detect cancer in the general population.
Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.